AI platform identifies synergistic drug combination for resistant prostate cancer
A UCLA artificial intelligence platform paired with three-dimensional tumor testing identified berberine and enzalutamide as a synergistic combination in four ...
A UCLA artificial intelligence platform paired with three-dimensional tumor testing identified berberine and enzalutamide as a synergistic combination in four ...
A review proposes that steroid refractoriness in acute graft-versus-host disease may arise from multiple abnormalities affecting receptor activation, nuclear translocation, ...
A 2026 review links lactate-driven protein lactylation to glioblastoma growth, stemness, immune escape and treatment resistance in preclinical models, while ...
A systematic review of 19 clinical studies found that miR-155 was associated with cancer treatment outcomes in a context-dependent way, ...
A new review details how acute myeloid leukemia remodels the bone marrow microenvironment to shelter both bulk blasts and leukemic ...
A new review in Molecular Cancer synthesizes how liquid-liquid phase separation shapes radiosensitivity, immune evasion, and treatment resistance in cancer.
A comprehensive review of drugs approved since 2018 reveals rapid innovation in schizophrenia, bipolar disorder and depression, while anxiety disorders ...
A new hypothesis proposes that chronic metabolic dysregulation epigenetically primes apoptosis-resistant cancer clones years before diagnosis, reframing treatment resistance as ...
A small exploratory study links distinct immature and inflammatory states of circulating high-density neutrophils to both resistance to immune checkpoint ...
An international study of 183 patients reveals that IDH-mutant gliomas follow divergent genetic evolutionary paths at recurrence, with oligodendrogliomas acquiring ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine